上海睿昂基因科技股份有限公司 2025年第三季度报告

Core Points - The company has announced the appointment of Zhonghui Certified Public Accountants as its auditing firm for the fiscal year 2025, pending approval from the shareholders' meeting [10][21][22] - The company plans to hold its fourth extraordinary shareholders' meeting on November 14, 2025, to discuss the appointment of the auditing firm and other matters [24][25] - The company reported a provision for asset impairment totaling 3,244,068.70 yuan for the third quarter of 2025, which includes credit impairment losses and inventory write-downs [36][40] Financial Data - The company intends to recognize credit impairment losses of 3,146,208.22 yuan for accounts receivable and other receivables [38] - An additional inventory write-down of 97,860.48 yuan has been proposed due to the cost of inventory exceeding its net realizable value [39] - The total impact of the impairment provisions on the company's profit for the third quarter of 2025 is expected to be a reduction of 3,244,068.70 yuan [40] Shareholder Information - The company has confirmed that the total number of shareholders and the status of major shareholders will be disclosed in the upcoming shareholders' meeting [5][6] - The company has a repurchase account holding 669,621 shares, representing 1.20% of the total share capital [6] Audit Firm Information - Zhonghui Certified Public Accountants has been in operation since December 2013 and has a significant number of registered accountants and partners [12][14] - The firm has not faced any civil liability in the past three years related to its auditing practices [14] - The audit fee for the company in 2025 is set at 1 million yuan, consistent with the previous year's fee [19]